X-134821550-G-A

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_001388447.1(PABIR3):​c.189+6701G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000061 in 1,148,255 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., 2 hem., cov: 22)
Exomes 𝑓: 0.000060 ( 0 hom. 14 hem. )

Consequence

PABIR3
NM_001388447.1 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.473

Publications

0 publications found
Variant links:
Genes affected
PABIR3 (HGNC:25202): (PABIR family member 3) Predicted to enable protein serine/threonine phosphatase inhibitor activity. Predicted to be involved in negative regulation of catalytic activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant X-134821550-G-A is Benign according to our data. Variant chrX-134821550-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2661481.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PABIR3NM_001388447.1 linkc.189+6701G>A intron_variant Intron 3 of 10 ENST00000645433.2 NP_001375376.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PABIR3ENST00000645433.2 linkc.189+6701G>A intron_variant Intron 3 of 10 NM_001388447.1 ENSP00000496338.1 A0A2R8Y7S4

Frequencies

GnomAD3 genomes
AF:
0.0000719
AC:
8
AN:
111324
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00225
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000332
AC:
35
AN:
105459
AF XY:
0.000158
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00436
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000598
AC:
62
AN:
1036877
Hom.:
0
Cov.:
32
AF XY:
0.0000416
AC XY:
14
AN XY:
336139
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24745
American (AMR)
AF:
0.00
AC:
0
AN:
27727
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18376
East Asian (EAS)
AF:
0.00217
AC:
58
AN:
26697
South Asian (SAS)
AF:
0.00
AC:
0
AN:
49446
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
26311
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4060
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
815537
Other (OTH)
AF:
0.0000910
AC:
4
AN:
43978
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000718
AC:
8
AN:
111378
Hom.:
0
Cov.:
22
AF XY:
0.0000596
AC XY:
2
AN XY:
33580
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30637
American (AMR)
AF:
0.00
AC:
0
AN:
10371
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2648
East Asian (EAS)
AF:
0.00226
AC:
8
AN:
3542
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2668
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5988
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53107
Other (OTH)
AF:
0.00
AC:
0
AN:
1513
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000529

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Dec 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PABIR3: BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.3
DANN
Benign
0.80
PhyloP100
0.47
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs768085823; hg19: chrX-133955580; API